In addition to its well-established role in hematologic malignancies, a growing body of evidence implicates CHIP in diverse CVD phenotypes, including coronary artery disease (CAD), heart failure (HF), and ischemic stroke [13]. This evidence concerns the gene STUB1 and ischemic stroke.